OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/12/2026
Back to search
Official data from USPTO
P5
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
08/12/2026
Trademark type
Word
Nice classes
1, 5, 42
Filing date
02/06/2025
Registration date
04/28/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/28/2026
Last transaction
08/12/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
27
Owner location
DE
Examiner
OAKES, JEFFREY ALLEN
Law office
O10
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Tubulis GmbH
Representatives
Ryan D. Artis Attorney of Record, NY Bar Member
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicalbiochemicalbiologicalbiotechnological preparationsin particularantibodiesfragments of antibodies and antibody-drug conjugates for industrial and scientific use; antibodiesfragments of antibodies and antibody-drug conjugates for the development or manufacture of therapeutic reagents for industrial and scientific use; biological preparationsin particularantibodiesfragments of antibodies and antibody-drug conjugates for laboratoriesdiagnostics and analytics for scientific or research use; chemicalbiochemicalbiologicalbiotechnological preparations for industrial and scientific use.
Class 5
Pharmaceutical and veterinary preparations and substances for the treatment of cancerinflammatory diseasesautoimmune diseasesinfective diseasescardiovascular diseasesliver metabolic disorders and other conditions which can be treated or ameliorated by antibodies binding toactivation or blocking ofa target antigen; therapeutic pharmaceuticalsnamely antibody-drug conjugates for the treatment of cancer and autoimmune diseases; pharmaceutical and veterinary preparations for the treatment of cancerinflammatory diseasesautoimmune diseasesinfective diseasescardiovascular diseases and liver metabolic disorders comprising small molecules; small molecule compounds being pharmaceuticals for the treatment of cancer
Class 42
Scientific and technological servicesnamely scientific researchanalysistesting and design in the fields of biologychemistry and medicineas well as in the fields of immunologyoncologymolecular biologycellular biologybiochemistry and medicinal chemistry as well as in the fields of discovery and development of pharmaceuticalsmedical and veterinary preparationsdiagnostic preparationsbiomarker reagents and diagnostic apparatus
Publications
History of USPTO decisions and trademark events.
26 publications found
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
08/12/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/28/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/28/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
04/28/2026
NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/16/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/10/2026
PUBO
PUBLISHED FOR OPPOSITION
03/10/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/04/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/13/2026
XAEC
EXAMINER'S AMENDMENT ENTERED
02/13/2026
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/13/2026
GNEA
EXAMINERS AMENDMENT E-MAILED
02/13/2026
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/13/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/04/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/04/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/04/2026
RFNT
REFUSAL PROCESSED BY IB
09/05/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/21/2025
RFRR
REFUSAL PROCESSED BY MPU
08/20/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/17/2025
CNRT
NON-FINAL ACTION WRITTEN
07/16/2025
DOCK
ASSIGNED TO EXAMINER
07/16/2025
MAFR
APPLICATION FILING RECEIPT MAILED
03/16/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/16/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/13/2025
Continuous trademark protection
Get notified about every new filing that threatens P5 or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.